SRXH

SRX Global Inc

1.51

Sep 04 • 3:59 PM ET -0.05 (-3.21%)

1.50

Aftermarket • 7:54 PM ET -0.01 (-0.66%)

Consumer Defensive Packaged Foods USA Nano AMEX

Sep 03, 8:50 AMSRX Global updates shareholders on positive interim data and new U.S. government and FDA milestones for lead anti-fentanyl candidate ARMR-100 at ARMR Sciences

Peers: BHST DDC BOF BRID FTLF LFVN HAIN BYND LWAY VITL

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	30.60M
Enterprise Value	-19.09M
Income	-
Sales	-
Book/sh	7.33
Cash/sh	2.45
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Jul 22, 2026
Dividend Gr. 3/5Y	- -
Payout	-
Employees	11
IPO	Jun 16, 2010

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.21
P/C	0.62
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	26.45
Current Ratio	27.55
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	66.93% 63.29%
Sales past 3/5Y	-50.74% -31.27%
EPS Y/Y TTM	108.28%
Sales Y/Y TTM	-
EPS Q/Q	98.37%
Sales Q/Q	-52.62%
Earnings	Aug 13 AMC
EPS/Sales Surpr.	- -

Insider Own	2.09%
Insider Trans	0.00%
Inst Own	3.69%
Inst Trans	4.92%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-14.28%
SMA50	-38.53%
SMA200	-82.37%
Trades

Shs Outstand	20.27M
Shs Float	19.84M
Short Float	8.45%
Short Ratio	0.36
Short Interest	1.68M
52W High	41.56 -96.37%
52W Low	0.94 61.28%
Volatility	6.36% 8.90%
ATR (14)	0.22
RSI (14)	34.32
Beta	0.95
Rel Volume	0.08
Avg Volume	4.69M
Volume	354,074

Perf Week	-11.70%
Perf Month	5.59%
Perf Quarter	-78.64%
Perf Half Y	-78.50%
Perf YTD	-88.69%
Perf Year	-93.24%
Perf 3Y	-99.73%
Perf 5Y	-99.98%
Perf 10Y	-100.00%
Recom	1.00
Target Price	600.00
Prev Close	1.56
Price	1.51
Change %	-3.21%

Sep-03-26 08:15AM	SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company (GlobeNewswire)
Aug-31-26 07:30AM	SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers (GlobeNewswire)
Aug-14-26 01:02AM	SRX Global Inc (SRXH) (Q3 2026) Earnings Call Highlights: Strategic EMJX Acquisition and Record ... (GuruFocus.com)
Aug-13-26 04:05PM	SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results (GlobeNewswire)
Aug-06-26 08:30AM	SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET (GlobeNewswire)
03:30PM	Loading…
Aug-04-26 03:30PM	SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics (NewMediaWire)
11:35AM	SRX Global Acquires Stake in Vistagen Therapeutics (InvestorsHub)
05:00AM	SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN) (GlobeNewswire)
Aug-03-26 08:44AM	SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger (GlobeNewswire)
Jul-30-26 02:04PM	SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering (GlobeNewswire)
Jul-16-26 09:00AM	SRX Global Regains Full Compliance with NYSE American Listing Standards (GlobeNewswire)
Jul-14-26 09:20AM	SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026 (GlobeNewswire) -15.69%
04:15AM	SRXH Stock Falls Premarket Ahead Of Eric Jackson's Fireside Chat Traders Brace For Buyback Clues And CEO Spotlight (Stocktwits)

SRX Global, Inc. is an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. SRX Global was founded on January 3, 2001 and is headquartered in Tampa, FL.

Chief Executive OfficerMr. Kent Cunningham

Chief Financial OfficerMs. Carolina Martinez

Founder & President of EMJX Platform and Head of Asset ManagementDr. Eric M. Jackson Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SRXH

SRX Global Inc

Upgrade your Finviz experience